MCCP
LLY icon

Mission Creek Capital Partners’s Eli Lilly LLY Stock Holding History

Mission Creek Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.45M Buy
4,541
+875
+24% +$894K 0.96% 33
2026
Q1 		$3.37M Buy
3,666
+496
+16% +$503K 0.67% 42
2025
Q4 		$3.41M Buy
3,170
+303
+11% +$290K 0.69% 37
2025
Q3 		$2.19M Buy
2,867
+1,637
+133% +$1.22M 0.43% 57
2025
Q2 		$959K Sell
1,230
-34
-3% -$26.4K 0.21% 98
2025
Q1 		$1.04M Buy
1,264
+19
+2% +$15.8K 0.25% 92
2024
Q4 		$961K Sell
1,245
-1,625
-57% -$1.35M 0.21% 112
2024
Q3 		$2.54M Buy
2,870
+99
+4% +$89K 0.59% 47
2024
Q2 		$2.51M Buy
2,771
+1,510
+120% +$1.21M 0.63% 43
2024
Q1 		$981K Buy
+1,261
New +$897K 0.26% 105

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mission Creek Capital Partners's LLY Position: Q2 2026 in Review

Mission Creek Capital Partners increased its Eli Lilly (LLY) stake by 24% in Q2 2026, buying an estimated $894K and bringing the position to 4,541 shares worth $5.45M. The position accounts for 0.96% of the portfolio, ranked #33.

Mission Creek Capital Partners first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,637 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mission Creek Capital Partners held 4,541 shares of Eli Lilly worth $5.45M as of Q2 2026.
  • Mission Creek Capital Partners bought 875 Eli Lilly shares in Q2 2026, an estimated $894K.
  • Eli Lilly made up 0.96% of Mission Creek Capital Partners's portfolio in Q2 2026, its #33 holding.
  • Mission Creek Capital Partners first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,637 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mission Creek Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.